Schizophrenia News and Research

Latest Schizophrenia News and Research

Childlessness increases risk of hospitalisations for psychiatric disorders among infertile women

While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis. Now, based on the largest cohort of women with fertility problems compiled to date, Danish investigators have shown that women who remained childless after their first investigation for infertility had more hospitalisations for psychiatric disorders than women who had at least one child following their investigation.

3 Jul 2012

ASD, schizophrenia and bipolar disorder share etiologic risk factors

New research led by a medical geneticist at the University of North Carolina School of Medicine points to an increased risk of autism spectrum disorders (ASDs) among individuals whose parents or siblings have been diagnosed with schizophrenia or bipolar disorder.

3 Jul 2012

Researchers demonstrate power of single-molecule sequencing

The next "next-gen" technology in genome sequencing has gotten a major boost.

2 Jul 2012

Oxytocin levels linked to medication dose, symptoms in schizophrenia

Higher doses of second-generation antipsychotics and more severe negative symptoms are associated with lower levels of oxytocin in cerebrospinal fluid among patients with schizophrenia, researchers report.

29 Jun 2012

Family history influences age at prodrome and psychosis onset

A family history of psychosis is associated with an earlier age at onset of both prodromal symptoms and full-blown psychosis, US research shows.

28 Jun 2012

Methylphenidate ‘could relieve cancer depression’

The drug methylphenidate is well tolerated among advanced cancer patients and shows promise in alleviating depression in this group, report researchers from Spain.

28 Jun 2012

BPI clinical study to evaluate computerized, brain-plasticity-based program for schizophrenia

Researchers at San Francisco-based Brain Plasticity, Inc. (BPI) have begun a multi-center study to evaluate the effects of a computerized, brain-plasticity-based program designed to address the cognitive issues associated with schizophrenia.

28 Jun 2012

Psychiatric inpatients have low vitamin D levels

Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.

27 Jun 2012

CAMH releases comprehensive reviews of most effective treatments for alcohol dependence

Scientists from the Centre for Addiction and Mental Health (CAMH) have released comprehensive reviews of the most effective treatments for alcohol dependence, one of the most prevalent addictions in Canada.

27 Jun 2012

Genetic risk for schizophrenia linked to brain volume alterations

Patients with schizophrenia and their unaffected first-degree relatives show altered gray and white matter volumes in specific brain regions compared with mentally healthy individuals, researchers report.

26 Jun 2012

Liability for schizophrenia linked to cognition in mood disorders

Schizotypal traits and genetic liability for schizophrenia are associated with reduced cognitive functioning in patients with mood disorders, Japanese study results show.

26 Jun 2012

Feinstein Institute to train clinicians on how to better care for patients with schizophrenia

The Zucker Hillside Hospital campus of the Feinstein Institute for Medical Research has been approved for a $9.3+ million federal grant to train clinicians on how to better care for patients with schizophrenia.

26 Jun 2012

Superior temporal sulcus perfusion linked to QoL in schizophrenia

Schizophrenia patients with a relatively high quality of life show hypoperfusion in the superior temporal sulcus compared with those with a relatively low quality of life.

22 Jun 2012

Amygdala volume reduced in schizophrenia, not psychotic BD

Amygdala volume is reduced in patients with schizophrenia compared with those who have psychotic bipolar disorder, researchers report.

22 Jun 2012

Alexza resubmits ADASUVE NDA to U.S. FDA

Alexza Pharmaceuticals, Inc. announced today that it has resubmitted its ADASUVE New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2012.

22 Jun 2012

CDSS best for assessing depression symptoms in schizophrenia

Results from a systematic review of published studies suggests that the Calgary Depression Scale for Schizophrenia is the most reliable and valid instrument for assessing depression symptoms in patients with schizophrenia.

21 Jun 2012

Study to test NAC and aspirin for people diagnosed with bipolar disorder

A commonly available pharmaceutical drug with anti-inflammatory properties and a nutritional supplement thought to have antioxidant effects are now being tested at The University of Texas Health Science Center at Houston (UTHealth) as add-on therapies for people diagnosed with bipolar disorder.

21 Jun 2012